Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This locus represents a novel transcript identified within the intronic region of the AMZ2 gene on the sense strand. Novel transcripts are discovered using long-read RNA sequencing and transcriptome assembly tools such as Bambu, IsoQuant, and FLAIR, typically in large RNA-seq studies. These transcripts often lack annotation regarding protein-coding capability, biological function, and disease relevance. Many “novel” transcripts, particularly those intronic to known genes, can be artifacts of sequencing, represent uncharacterized lncRNAs, or be non-functional remnants of pervasive transcription. Currently, there is no evidence that this transcript encodes a protein or is involved in classic molecular pathways amenable to therapeutic targeting. Further validation and functional studies are required before its biological or clinical relevance can be established[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to AMZ2.